Sunshine Biopharma (SBFM) Operating Expenses (2010 - 2026)
Sunshine Biopharma's (SBFM) quarterly Operating Expenses came in at $4.5 million in Q1 2026, down 13.3% YoY from $5.2 million in Q1 2025, and down 30.11% on a QoQ basis from $6.4 million in Q4 2025.
Sunshine Biopharma (SBFM) Operating Expenses (2010 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 16 years of Operating Expenses data on file, last reported at $4.5 million in Q1 2026.
- Quarterly Operating Expenses fell 13.3% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.3 million (up 7.26% YoY) and the FY2025 annual result came in at $23.0 million, up 11.82% from the prior year.
- Operating Expenses eased to $4.5 million in Q1 2026, from $6.4 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $24.9 million in Q4 2022 to a low of $817363.0 in Q2 2022.
- A 5-year average of $5.5 million and a median of $4.8 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 6208.37% — and 2023, when it slumped 78.74%.
- Tracing SBFM's Operating Expenses over 5 years: stood at $24.9 million in 2022, then tumbled by 78.74% to $5.3 million in 2023, then climbed by 16.9% to $6.2 million in 2024, then rose by 3.62% to $6.4 million in 2025, then plunged by 30.11% to $4.5 million in 2026.
- The last three Operating Expenses figures came in at $4.5 million (Q1 2026), $6.4 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | 4.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.81 Mn |
| Mar 31, 2026 | 4.48 Mn |
| Dec 31, 2025 | 6.41 Mn |
| Sep 30, 2025 | 4.89 Mn |
| Jun 30, 2025 | 6.48 Mn |
| Mar 31, 2025 | 5.17 Mn |
| Dec 31, 2024 | 6.19 Mn |
| Sep 30, 2024 | 4.63 Mn |
| Jun 30, 2024 | 4.77 Mn |
| Mar 31, 2024 | 4.84 Mn |
| Dec 31, 2023 | 5.29 Mn |
| Sep 30, 2023 | 3.55 Mn |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 4.09 Mn |
| Dec 31, 2022 | 24.90 Mn |
| Sep 30, 2022 | 2.15 Mn |
| Jun 30, 2022 | 817,363.00 |
| Mar 31, 2022 | 1.65 Mn |
| Dec 31, 2021 | 394,658.00 |
| Sep 30, 2021 | 749,594.00 |